The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ultravist 370mg/ml Solution for Injection (50 ml, 100ml, 150 ml, and 200 ml)

370 milligram(s)/millilitre Solution for injection

Bayer LimitedPA1410/011/004

Main Information

Trade NameUltravist 370mg/ml Solution for Injection (50 ml, 100ml, 150 ml, and 200 ml)
Active SubstancesIopromide
Strength370 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderBayer Limited
Licence NumberPA1410/011/004

Group Information

ATC CodeV08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
V08AB05 iopromide


Licence Issued24/09/1986
Legal statusProduct subject to Restricted Prescription (C)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back